Open AccessAssessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014–2017 BRFSS
Author(s) -
Billy A. Caceres,
Kasey B. Jackman,
Donald Edmondson,
Walter Bockting
Publication year - 2019
Publication title -
journal of behavioral medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 94
eISSN - 1573-3521
pISSN - 0160-7715
DOI - 10.1007/s10865-019-00102-8
Subject(s) - transgender , medicine , overweight , demography , population , stressor , odds ratio , gerontology , myocardial infarction , behavioral risk factor surveillance system , diabetes mellitus , clinical psychology , obesity , environmental health , psychology , endocrinology , sociology , psychoanalysis
The purpose of this study was to assess gender identity differences in CVD risk and CVD conditions among adults in the U.S. Using data from the 2014-2017 BRFSS we compared CVD risk and CVD conditions in gender minorities (transgender men, transgender women and gender nonconforming persons) to both cisgender men and women. The sample consisted of 662,903 participants. Transgender women (AOR 1.34, 95% CI 1.05-1.72) and transgender men (AOR 1.54, 95% CI 1.07-2.24) were more likely to be overweight than cisgender women. Compared to cisgender women, transgender women reported higher rates of diabetes (AOR 1.45, 95% CI 1.05-1.99), angina/coronary heart disease (AOR 1.90, 95% CI 1.34-2.68), stroke (AOR 1.88, 95% CI 1.16-3.03), and myocardial infarction (AOR 2.98, 95% CI 2.14-4.17). Gender nonconforming participants (AOR 2.68, 95% CI 1.14-6.30) reported higher odds of myocardial infarction than cisgender women. Transgender women also had higher rates of reporting any CVD than cisgender men (AOR 1.38, 95% CI 1.01-1.88). There is a need to elucidate the cardiovascular effects of minority stressors and gender affirming therapy in this population. More research focused on CVD prevention and management in gender minorities is recommended.